S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Galectin Therapeutics Inc (GALT)
Galectin Therapeutics Inc (GALT) Financials

GALT Galectin Therapeutics Inc

3.03

-0.22 (-6.77%)

After Hours

Last Updated: 06:30:00

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-105.917	-175.055	-228.556	-70.221	-60.466	-85.956	-123.187	-181.085
Return on Equity (%)	-157.772	-357.857	-647.879	-82.284	-71.153	-262.792	235.423	93.46
Return on Invested Capital (%)	-151.588	-291.591	-359.129	-51.541	-67.439	-108.24	-195.22	-407.253
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	0.234	0.026	0.12	0.571	0.303	0.032	-0.391	-0.717
Earnings Per Share	-0.509	-0.374	-0.261	-0.253	-0.295	-0.373	-0.472	-0.529
Cash Per Share	0.35	0.065	0.143	0.595	0.339	0.482	0.226	0.303
Working Capital Per Share	0.274	0.018	0.117	0.569	0.301	0.399	0.092	0.142
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	-0.488	-0.347	-0.241	-0.167	-0.293	-0.371	-0.471	-0.485
EBITDA Per Share	-0.488	-0.347	-0.241	-0.167	-0.293	-0.371	-0.471	-0.485
Free Cash Flow Per Share	-0.509	-0.374	-0.261	-0.253	-0.296	-0.374	-0.472	-0.529

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	4.178	1.287	4.19	17.095	5.457	4.63	1.579	1.768
Quick Ratio	4.064	1.029	3.915	16.837	5.027	4.389	1.429	1.637
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	32.91M	35.79M	41.19M	56.9M	57.08M	59.34M	59.43M	N/A

Key Stats and Ratios

Year End 31 December 2023	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	N/A	59.4M	N/A	59.43M	N/A	59.58M	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	3.514	N/A	N/A	N/A	1.695	N/A	N/A	N/A
Quick Ratio	3.315	N/A	N/A	N/A	1.543	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	186.78M
Price to Earnings Ratio	-4.17
Price to Sales Ratio	0
Price to Cash Ratio	7.28
Price to Book Ratio	-3.1
Dividend Yield	-

Share Statistics

Shares Outstanding	61.85M
Average Volume (1 week)	142.83k
Average Volume (1 Month)	200.58k
52 Week Change	72.16%
52 Week High	4.2684
52 Week Low	1.28

More Ratios Coming Soon!

Galectin Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions